Beckman Coulter Access System-GI Monitor Recalled for Biotin Interference
Beckman Coulter is recalling Access System-GI Monitor (CA19-9) kits because they are susceptible to biotin interference, which may affect test results.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any hospitalizations, injuries, or deaths. The hazard is a susceptibility to interference rather than a direct physical injury or high-risk pathogen, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Beckman Coulter Inc. is recalling the Access System-GI Monitor (CA19-9), A83873D, Catalog No. 387687. The recall involves 249,597 units total, with 9,388 units distributed in the United States. The product was distributed to numerous countries worldwide, including the United States, Canada, and various nations in Europe, Asia, Africa, and the Americas.
The recall is being conducted because the Access immunoassays are susceptible to biotin interference. This susceptibility may impact the accuracy of the test results. The source text does not specify reported illnesses, injuries, or deaths associated with this recall.
Healthcare providers and laboratories should stop using the affected product and contact Beckman Coulter for further instructions or replacement units. Consumers should consult their healthcare provider if they have recently used this test.
The recalled product
- Product
- Access System-GI Monitor (CA19-9), A83873D, Catalog No. 387687
- Manufacturer
- Beckman Coulter Inc.
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots
Distribution
Part of a larger recall action
This product is one of 4 recalled by Beckman Coulter Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Beckman Coulter Inc.
See all →- ModerateBeckman Coulter Recalls DxC 500i Clinical Analyzer Modules Due to Software Error
FDA (Devices) · 2026-10-14
- ModerateBeckman Coulter DxC 500 AU Clinical Chemistry Analyzers Recalled for Software Error
FDA (Devices) · 2026-10-14
- HighBeckman Coulter DxC 500 AU Analyzer Software Defect Recall
FDA (Devices) · 2026-08-26
- HighBeckman Coulter DxC 500i Analyzer Modules Recalled for Software Defect
FDA (Devices) · 2026-08-26
- High
Same hazard · biotin interference
See all →- HighBeckman Coulter Access Free T4 Thyroxine Assay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- HighBeckman Coulter Access Thyroglobulin Antibody II Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Access Total T3 Assay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Free T3 Immunoassay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Access GI Monitor Cancer Antigen 19-9 Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
Similar recalls
- ModerateBeckman Coulter Access GI Monitor Cancer Antigen 19-9 Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Access Thyroglobulin Immunoassay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- HighBeckman Coulter Access Thyroglobulin Antibody II Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Access Total T3 Assay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Free T3 Immunoassay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Recalls Access 2 Immunoassay Systems Due to Circuit Board Defect
FDA (Devices) · 2017-04-12